coronavirus

COVID-19 deaths are increasing in Africa, WHO warns

The World Health Organization (WHO) has expressed concerns about the trend of COVID-19 deaths in Africa. Addressing the 150th Executive Board Meeting of the WHO, the organization’s Director-General, Dr. Tedros Adhanom Ghebreyesus noted that while the number of deaths from the pandemic is rising, it is particularly increasing in Africa where the least proportion of citizens have been vaccinated. “So far, the explosion in cases has not been matched by a surge in deaths, although deaths are increasing in all regions,

WHO recommends against the use of convalescent plasma to treat COVID-19

The World Health Organization (WHO) has updated its living guideline on COVID-19 therapeutics to include convalescent plasma. For non-severe COVID-19 patients, WHO recommends against its use, while it should only be used within clinical trials for severe and critical COVID-19 patients. Convalescent plasma is a transfusion of blood plasma from someone who has recovered from COVID-19. Current evidence shows that convalescent plasma does not improve survival or reduce the need for mechanical ventilation, while it has significant costs. An independent panel of experts,

Only 1 in 4 African health workers fully vaccinated against COVID-19

Only 27% of health workers in Africa have been fully vaccinated against COVID-19, leaving the bulk of the workforce on the frontlines against the pandemic unprotected, a preliminary analysis by World Health Organization (WHO) shows. Analysis of data reported from 25 countries finds that since March 2021, 1.3 million health workers were fully vaccinated, with just six countries reaching more than 90%, while nine countries have fully vaccinated less than 40%. In sharp contrast, a recent WHO global study of 22

Regulator recommends lower dosage of Pfizer COVID-19 vaccine for children

European Medicines Agency’s (EMA) human medicines committee has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 5 to 11. The vaccine, developed by BioNTech and Pfizer, is already approved for use in adults and children aged 12 and above. In children from 5 to 11 years of age, the dose of Comirnaty will be lower than that used in people aged 12 and above (10 µg compared with 30 µg).

WHO warns COVID-19 more deadly in Africans with diabetes

Africa’s sharp increase in diabetes is clashing with the COVID-19 pandemic and poor access to vaccines. Africa’s death rates from COVID-19 infections are significantly higher in patients with diabetes, according to a preliminary analysis which the World Health Organization (WHO) presented today in advance of the World Diabetes Day on 14 November. “COVID-19 is delivering a clear message: fighting the diabetes epidemic in Africa is in many ways as critical as the battle against the current pandemic,” said Dr Matshidiso Moeti,

The world’s first pill to treat COVID-19 set for approval

Merck and Merck and Ridgeback Biotherapeutics today announced that the submission of an Emergency Use Authorization (EUA) application to the U.S. Food and Drug Administration (FDA) for molnupiravir, an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in adults who are at risk for progressing to severe COVID-19 and/or hospitalization. The companies are actively working with regulatory agencies worldwide to submit applications for emergency use or marketing authorization in the coming months. The submission is based on positive results

COVID-19, funding shortfalls are devastating efforts to end Tuberculosis by 2030 – report

The Stop TB Partnership today released new data showing how the COVID-19 pandemic and dismally low levels of funding represent the main barriers to achieving the United Nations Sustainable Development Goals of ending TB by 2030. The data from 2021 shows that the impact of COVID-19 on the TB response has continued to be profound: 1.2 million fewer people have been diagnosed and treated for TB in in 2021 with four months still left in the calendar year. Currently, only

Africa faces 470 million COVID-19 vaccine shortfall in 2021

As the COVAX Facility is forced to slash planned COVID-19 vaccine deliveries to Africa by around 150 million this year, the continent faces almost 500 million doses short of the global year-end target of fully vaccinating 40% of its population. This shortfall comes as Africa tops 8 million COVID-19 cases this week.    With the cutback COVAX is now expected to deliver 470 million doses to Africa this year. These will be enough to vaccinate just 17% of the population, far

Nigeria reopens COVID-19 vaccination registration portal as vaccine rollout resumes

The Federal Government has launched the second phase of the COVID-19 vaccination on 16 August 2021 in Abuja; A continuous effort towards curbing the spread of the disease in the country. Citizens can now register online by clicking here to book a vaccination appointment at their preferred and nearest vaccination site. At a symbolic event to flag- off the second phase at the Federal Medical Centre (FMC), Abuja, the Chairman of the Presidential Steering Committee (PSC)

COVID-19 will end when the world chooses to end it — WHO DG

WHO Director-General, Dr Tedros Adhanom Ghebreyesus, has revealed that the end to the COVID-19 pandemic is possible anytime the world wants to end it as the solutions are now available. Addressing the WTO – WHO High Level Dialogue: Expanding COVID-19 Vaccine Manufacture To Promote Equitable Access, the DG said the tools to end the COVID-19 pandemic are now available. “It (the pandemic) will end when the world chooses to end it, because the solutions are in our hands. We have all